Injecting viral peptides systemically into mice activated immune cells that then targeted pancreatic tumors, opening avenues to more accessible cancer therapy.
Pancreatic cancer is deadly; only about 10% of patients live over five years after they are diagnosed. Patients can be treated in several ways, including with chemotherapy and surgery. Immunotherapies ...
Pancreatic cancer is one of the deadliest types of tumors. A team at the Technical University of Munich (TUM) has discovered that pancreatic tumors exploit the body’s nervous system by forming ...
PNETs are classified as functional or non-functional, influencing symptoms and treatment strategies. Tumor grade impacts prognosis and treatment plans. Diagnosis involves imaging, blood tests, and ...
Morning Overview on MSN
AI blood test spots early pancreatic cancer with up to 94% accuracy
Researchers at Academia Sinica and National Taiwan University Hospital have developed an AI-powered blood test that detects early-stage pancreatic cancer with near-perfect accuracy in validation ...
CHICAGO -- For the first time in a phase III trial, overall survival (OS) in unresectable pancreatic cancer improved significantly versus chemotherapy with the addition of tumor treating fields ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results